What Is Ketamine Cream Used For and How Does It Work?

Ketamine cream is a compounded topical medication used primarily to treat localized pain, especially nerve-related pain that has not responded well to standard treatments. Unlike intravenous or oral ketamine, which act on the brain and carry risks of dissociation and sedation, the cream is applied directly to the skin over painful areas and works largely through receptors in the skin itself. Most of the evidence supporting it centers on conditions like complex regional pain syndrome, post-herpetic neuralgia, and diabetic neuropathy, though its uses have been expanding into post-surgical recovery and even psychiatric symptom management.

How Ketamine Cream Works at the Skin Level

Ketamine is best known as an anesthetic and, more recently, as a treatment for depression when given intravenously. But when applied to the skin, its pharmacology shifts in meaningful ways. The cream targets NMDA receptors, which are found not just in the brain and spinal cord but also on nerve endings in the skin called cutaneous nociceptors. These receptors play a role in amplifying pain signals, particularly in conditions where the nervous system has become hypersensitive. By blocking NMDA receptors locally, ketamine can quiet that amplified signaling without the drug needing to reach the brain in significant amounts. A controlled trial in patients with complex regional pain syndrome found that topical ketamine reduced allodynia (pain from light touch) and hyperalgesia (exaggerated pain from mildly painful stimuli), while blood levels of ketamine remained undetectable, confirming the effect was local rather than systemic.¹

NMDA receptor blockade is only part of the story. Ketamine also blocks voltage-gated sodium channels, the same channels targeted by local anesthetics like lidocaine. Laboratory studies have shown that ketamine blocks these channels in a manner very similar to traditional local anesthetics, and that the two drugs share a binding site within the channel’s pore.² This dual action means ketamine cream can reduce pain through two distinct pathways simultaneously: dampening the sensitized nerve signaling that characterizes chronic pain, and numbing the area in a more traditional local-anesthetic fashion.

A third mechanism involves inflammation. Ketamine has been shown to lower levels of pro-inflammatory mediators and suppress early postoperative inflammation when applied topically. In cases involving tissue damage or surgical wounds, this anti-inflammatory action may complement the pain-blocking effects, reducing swelling and redness alongside the pain itself.³

Neuropathic Pain Conditions

The strongest body of evidence for ketamine cream involves neuropathic pain, the type caused by damaged or malfunctioning nerves rather than by ongoing tissue injury. Several specific conditions come up repeatedly in the clinical literature.

Complex regional pain syndrome, or CRPS, is one of the most studied. CRPS typically develops in a limb after an injury or surgery and involves burning pain, swelling, and changes in skin color and temperature. The double-blind trial mentioned earlier demonstrated that topical ketamine applied to the affected limb could specifically reduce the painful sensitivity to touch and pinprick stimulation that makes CRPS so debilitating.¹ In a separate case report, a patient with CRPS type 1 who used ketamine cream at a 10% concentration combined with palmitoylethanolamide saw pain drop by more than half after one month, along with visible reduction in swelling and skin discoloration.⁴

Post-herpetic neuralgia, the persistent nerve pain that can follow a shingles outbreak, is another condition where ketamine cream has shown promise. A combination cream containing amitriptyline and ketamine (sometimes called AmiKet) produced pain relief comparable to oral gabapentin, one of the standard first-line drugs for this condition.⁵ That comparison matters because gabapentin works but comes with side effects like drowsiness, dizziness, and cognitive fog, drawbacks that a topical cream largely avoids.

Diabetic painful neuropathy, the burning and tingling in the feet and hands that affects many people with diabetes, has also been studied. The same amitriptyline-ketamine combination showed a strong trend toward pain reduction in diabetic neuropathy patients, though the evidence here is not as definitive as it is for post-herpetic neuralgia.⁵

Why Ketamine Is Often Combined With Other Drugs

You will rarely find ketamine cream prescribed as a single-ingredient formulation. Most compounded versions pair it with one or more other active ingredients, and there are practical reasons for this beyond just stacking pain relief.

The most common pairing is amitriptyline (2%) with ketamine (1%). An open-label trial following 28 patients with moderate to severe peripheral neuropathic pain found that this combination produced an average pain reduction of about 34% at six months and about 37% at twelve months, with roughly 40% of patients achieving at least a 50% reduction in pain by the one-year mark.⁶ These patients had already failed other treatments, making those numbers more impressive than they might look on paper. The cream was well tolerated over the full year, with no serious adverse events.

Lidocaine is another frequent partner. A study of patients using a cream containing both lidocaine and ketamine found that about 73% of patients overall benefited from the combination.⁷ The logic behind this pairing is straightforward: since ketamine and lidocaine both block sodium channels through overlapping but not identical mechanisms, combining them can produce broader nerve-quieting effects than either alone.

In pediatric oncology, a triple-combination cream containing amitriptyline, ketamine, and lidocaine (AKL cream) has been used for children with cancer-related neuropathic pain. A study of 53 patients found that pain scores dropped significantly within a few days of starting the cream compared to baseline.⁸ For children, topical options are especially valuable because systemic painkillers carry heavier side-effect burdens in growing bodies, and reducing opioid exposure in young patients is a persistent clinical goal.

Other agents sometimes compounded with ketamine include gabapentin, clonidine, and baclofen. A percutaneous absorption study found that when these drugs were compounded together in a transdermal base, ketamine actually had the highest overall absorption rate of the group, peaking at six to ten hours after application, which means it provides a slower and more sustained release compared to some of its companion ingredients.⁹

Acute and Post-Surgical Pain

While most of the attention around ketamine cream focuses on chronic conditions, there is growing interest in using it for acute pain, particularly after surgery. A case report documented the use of topical ketamine on a patient recovering from surgery for Fournier’s gangrene, a severe necrotizing soft-tissue infection. The cream provided meaningful pain relief in the postoperative period, and the authors noted that ketamine’s anti-inflammatory properties may have been especially helpful given the intense inflammatory response that accompanies necrotizing infections.³

In a study of patients with sympathetically maintained pain, ketamine prepared in a pluronic lecithin organogel was applied to affected limbs. Pain reduction ranged from 65% to 100% relative to pretreatment scores, with the initial response occurring within 20 seconds to three minutes. No side effects were reported at 24 or 48 hours of follow-up.¹⁰ That onset speed is fast for a topical, and likely reflects the sodium-channel-blocking action working almost immediately on superficial nerve fibers, while the deeper NMDA-related effects build over a longer timeframe.

Why Topical Ketamine Is Safer Than Other Routes

The safety question around ketamine is justified. When given intravenously or taken orally, ketamine can cause dissociation, hallucinations, elevated blood pressure, nausea, and a sense of detachment from reality. At higher or repeated doses, there are concerns about bladder damage and potential for psychological dependence. A systematic review in JAMA Network Open examined the psychiatric effects associated with ketamine use, underscoring that systemic administration carries real neuropsychiatric risks.¹¹

Topical application largely sidesteps these concerns. When ketamine cream is rubbed into the skin over a painful area, the drug concentrates in the local tissue rather than flooding the bloodstream. The CRPS trial that measured blood levels found them below the limit of detection, meaning essentially no ketamine was reaching the brain.¹ Without systemic absorption, the dissociative and psychotomimetic effects that make intravenous ketamine risky simply do not arise at typical topical doses. No psychogenic or other harmful systemic adverse events have been reported in studies of topical formulations, even in patients who used the cream over extended periods.

This safety profile is what makes ketamine cream appealing for populations where systemic drugs are problematic. Older adults managing post-herpetic neuralgia already take multiple medications and are vulnerable to drug interactions and sedation. Children with cancer face chemotherapy-related neuropathy but should not be exposed to unnecessary systemic drugs. People with a history of substance use disorders may reasonably want to avoid any form of opioid or sedative. For all of these groups, a topical that works locally with minimal bloodstream exposure fills a gap that oral medications cannot.

How Ketamine Cream Is Made and Applied

Ketamine cream is not available as a mass-produced pharmaceutical product. It is a compounded medication, meaning a compounding pharmacy prepares it to a prescriber’s specific instructions. This has practical implications you should be aware of.

The concentration of ketamine varies widely depending on the condition and the prescribing clinician’s judgment. Studies have used concentrations ranging from 1% in combination creams all the way up to 10% or higher for single-agent applications. The base (the substance the ketamine is mixed into) also matters. Pluronic lecithin organogel, or PLO, is a common choice because it enhances skin penetration.¹⁰ Other bases, such as lipoderm or Versabase, are also used and may have different absorption profiles.

Application is typically straightforward. You apply a measured amount to the skin over or near the painful area and rub it in. Some formulations come in calibrated applicators that dispense a consistent dose. The absorption timeline depends on the formulation and what other drugs are included. In multi-drug compounded creams, ketamine peaks in the skin at roughly six to ten hours after application, providing sustained release rather than a quick spike and fade.⁹ However, for single-agent formulations applied to sympathetically maintained pain, the onset has been reported in as little as 20 seconds, suggesting the base and concentration dramatically affect how quickly you feel relief.

Because these are compounded products, quality can vary from pharmacy to pharmacy. There is no FDA-approved standardized ketamine cream, which means no guarantee that two compounding pharmacies will produce a product with identical potency, absorption characteristics, or shelf life. If you are prescribed one, it is worth asking your prescriber whether they have a compounding pharmacy they trust and have worked with before.

Emerging Psychiatric Applications

One of the more unexpected directions for ketamine cream is its potential use in managing psychiatric symptoms, particularly those associated with PTSD. The rationale is that even small amounts of ketamine reaching the central nervous system through the skin might modulate glutamate signaling enough to affect mood and trauma-related symptoms, while avoiding the intense dissociation of intravenous infusions. Early reports suggest that a substantial majority of patients with treatment-resistant depression, anxiety, and PTSD-associated symptoms experienced symptom relief using ketamine cream, with no psychogenic adverse events observed. This is preliminary work and should be interpreted cautiously; controlled trials comparing topical ketamine to placebo for psychiatric conditions are still needed before this becomes an established use.

The idea is intriguing because the current delivery options for ketamine in psychiatry are limited. Intravenous infusions require clinic visits and monitoring, nasal esketamine (Spravato) carries regulatory restrictions and must also be administered in a clinical setting, and oral ketamine has inconsistent absorption and higher side-effect rates. A cream that patients could apply at home with a low risk profile would be transformative if the psychiatric benefits hold up under rigorous study.

Limitations and What the Evidence Does Not Yet Show

For all its promise, ketamine cream has some significant gaps in the evidence base. Most of the published studies are small: case reports, open-label trials with a few dozen patients, and small controlled trials. Large randomized controlled trials of the kind that would lead to FDA approval of a standardized product have not been completed. This does not mean the cream does not work, but it does mean the precise magnitude of its benefits, and which patient populations benefit most, remain somewhat fuzzy.

The compounded nature of the product introduces another layer of uncertainty. Because formulations differ between pharmacies, and because the base, concentration, and companion drugs all affect absorption and efficacy, results from one study may not translate perfectly to the cream you receive from your pharmacy. A patient who responds well to a 10% ketamine PLO gel might not respond the same way to a 5% ketamine lipoderm cream, even though both are technically “ketamine cream.”

Insurance coverage is another practical hurdle. Compounded medications are frequently not covered by insurance plans, and ketamine cream can be expensive out of pocket. Costs vary, but multi-ingredient compounded pain creams can run anywhere from $50 to several hundred dollars per month depending on the formulation and the pharmacy. If your prescriber recommends ketamine cream, it is worth checking with both your insurance and the compounding pharmacy about expected costs before starting.

Finally, while topical ketamine is far safer than systemic ketamine in terms of abuse potential and psychiatric side effects, it is still a controlled substance in many jurisdictions. Prescriptions may require specific documentation, and not all physicians are comfortable prescribing it. Pain specialists, palliative care clinicians, and some dermatologists are the most likely to be familiar with its use and the compounding process involved.

Who Might Be a Good Candidate

Ketamine cream tends to be considered when other options have failed or are poorly tolerated. If you have localized neuropathic pain and oral medications like gabapentin, pregabalin, or duloxetine are causing unacceptable side effects, a topical approach can target the painful area without those systemic drawbacks. If you have CRPS and the allodynia makes even clothing unbearable against your skin, ketamine cream applied to the affected limb has some of the most direct evidence behind it.¹

Patients managing post-herpetic neuralgia who are already on multiple medications, older adults at risk for drug interactions, and children with chemotherapy-induced neuropathy all represent populations where the low-systemic-absorption profile of ketamine cream is especially attractive.⁸ The cream is not a first-line treatment for garden-variety aches and pains, and it is unlikely to help with pain that is primarily inflammatory (like a sprained ankle) or mechanical (like a herniated disc pressing on a nerve root deep in the spine). Its sweet spot is superficial or peripheral nerve pain where the problem is in the nerve endings themselves, close enough to the skin surface for a topical drug to reach them.